December 11, 2001 - Discovery Laboratories and Quintiles today announced a sales and marketing alliance to commercialize in the U.S. Discovery's Surfaxin(R).

August 22, 2001 - Quintiles and Novia today announced a strategic alliance to provide preclinical services for Novia's lead compound to treat central nervous system (CNS) disorders.

July 30, 2001 - Quintiles Transnational and Synigence PLC today announced an exclusive co-marketing agreement to electronically deliver healthcare information and services to general practitioners in the United Kingdom via Synigence's Clinnix Pro application

June 26, 2001 - Pilot Therapeutics, a leading developer of natural therapeutics to treat chronic diseases, and Quintiles today announced an alliance to commercialize Pilot's lead product, the first clinically validated natural therapy for people with asthma.

June 12, 2001 - Quintiles Transnational Corp. and Care Capital LLC today announced the formation of a strategic alliance to provide life science companies with a broad range of operating, technical, scientific and investment support.

June 5, 2001 - Quintiles' corporate venture group to make equity investment in Innapharma

May 2, 2001 - Quintiles Transnational Corp. and ArgoMed Inc. today announced a strategic alliance to commercialize ArgoMed's Thermoflex™ Water Induced Thermotherapy System used for the treatment of benign prostatic hyperplasia.

March 21, 2001 - Meristem®Therapeutics and Quintiles Inc. today announced the formation of a strategic alliance to help biotechnology and pharmaceutical companies accelerate the development of therapeutic proteins.